What we do
About us
News & events
Investors
Careers
What we do
About us
News & events
Investors
Overview
Press releases
Events & presentations
Corporate Governance
Shareholder & stock info
Financial reports
Financial calendar
Rights Issue and Directed Issue 2023
Careers
Back
Back
Immunicum reports continued promising survival data for INTUVAX-treated renal cancer patients
8:30:00 AM
Keep reading
Immunicum presents safety and survival data from a clinical phase I/II study with INTUVAX in patients with liver cancer
Read